Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 4.35 +1.44%
ABUS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $657.55M
- P/E (TTM)
- 5.43
- EPS (TTM)
- $0.79
- Dividend yield
- None
- 52-week range
- 3.50 – 5.45
- Day range
- 4.28 – 4.48
- Volume / Avg
- 4.79M / 4.65M
- Beta
- —
- Shares outstanding
- 153.28M
52-week range
ABUS stock today
On Oct 7, ABUS ended the session at $4.29, shedding $0.19 (4.24%), versus the S&P 500's 0.22% decline. Shares are 21.3% below their 52-week high of $5.45, set on Aug 21, 2026 and 22.6% above the 52-week low of $3.50, in the middle of the past year's range. ABUS is down 10.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 0.0%.
Arbutus Biopharma trades at 5.4x its trailing twelve-month earnings per share of $0.79.
Summary generated from market data by MetaCap's automated system. Methodology
About Arbutus Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Warminster, PA
ABUS news
All ABUS newsArbutus Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CYRXCryoPort Inc. | 17.35 | -2.53% | $878.76M | vs ABUS |
| ALMSAlumis Inc. | 6.77 | -2.31% | $876.28M | vs ABUS |
| RIGLRigel Pharmaceuticals Inc. | 47.99 | +4.08% | $896.45M | vs ABUS |
| JBIOJade Biosciences Inc. | 13.77 | +2.68% | $875.74M | vs ABUS |
| CRVSCorvus Pharmaceuticals Inc. | 10.41 | -1.42% | $875.70M | vs ABUS |
| ANLAdlai Nortye Group Ltd. ADR | 14.05 | -2.84% | $904.79M | vs ABUS |
| MLTXMoonLake Immunotherapeutics Class A | 10.77 | -1.64% | $916.60M | vs ABUS |
| ANROAlto Neuroscience Inc. | 23.52 | -0.72% | $922.97M | vs ABUS |
Indexes, lists and sector
Largest Health Care stocks
Arbutus Biopharma stock FAQ
What is Arbutus Biopharma's stock price today?
ABUS last traded at $4.29 as of Oct 7, 4:00 PM EDT, down 4.24% on the day. Prices are delayed at least 15 minutes.
Does Arbutus Biopharma pay a dividend?
No. Arbutus Biopharma does not currently pay a regular cash dividend.
What is ABUS's P/E ratio?
ABUS trades at a trailing P/E ratio of 5.43.
Has ABUS ever split its stock?
Yes. The most recent ABUS stock split was a 1-for-5 split on Nov 4, 2010.
What is the ABUS 52-week high?
The 52-week high for ABUS is $5.45 and the 52-week low is $3.50. The stock is currently 21.3% below its high.